J&J/McNeil Withdraws Pancrease From U.S. Market
This article was originally published in The Pink Sheet Daily
The firm's Pancrease MT pancreatic enzyme product will remain on the market.
You may also be interested in...
Settlement requires that Impax cease marketing practices implying Lipram-CR is a generic equivalent to Creon branded products.
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.